Willingness to pay for mass screening for prostate cancer: A contingent valuation survey

International Journal of Urology

Volumn 15, Issue 1, 2008, Pages 102-105

  Yasunaga, Hideo ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cancer screening; Contingent valuation method; Prostate specific antigen; Willingness to pay

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; ARTICLE; CANCER SCREENING; CONTINGENT VALUATION; HEALTH CARE COST; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; QUESTIONNAIRE;

HEALTH CARE SURVEYS; HEALTH EXPENDITURES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; JAPAN; MALE; MASS SCREENING; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS;

EID: 37849000491     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2007.01931.x     Document Type: Article

References (10)

1. Yasunaga H, Ide H, Imamura T, Ohe K. Benefit evaluation of mass screening for prostate cancer: willingness to pay measurement using contingent valuation. Urology 2006 68 : 1046 50.
2. Klose T. The contingent evaluation method in health care. Health Policy 1999 47 : 97 123.
3. Conference of Prostate Cancer Screening The Japanese Foundation for Prostate Research. Medical tests for prostate problems in executive check-ups between 1989 and 1999. National statistics of mass screening for prostate cancer between 1986 and 1999. Hinyokigeka Jpn. J. Urol. Surg. 2003 16 : 1023 38.
4. Catalona WJ, Richie JP, Ahmann FR et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6630 men. J. Urol. 1994 151 : 1283 90.
5. Gustafsson O, Norming U, Almgard LE et al. Diagnostic methods in the detection of prostate cancer: a study of a randomly selected population of 2400 men. J. Urol. 1992 148 : 1827 31.
6. Keetch DW, Catalona WJ, Smith DS. Serial prostate biopsies in men with persistently elevated serum prostate specific antigen values. J. Urol. 1994 151 : 1571 4.
7. Yatani R, Shiraishi T, Nakakuki K et al. Trends in frequency of latent prostate carcinoma in Japan from 1965-1979 to 1982-1986. J. Natl. Cancer Inst. 1965 80 : 683 7.
8. Yasunaga H, Ide H, Imamura T, Ohe K. Women's anxieties caused by false positives in mammography screening: a contingent valuation survey. Breast Cancer Res. Treat. 2007 101 : 59 64.
9. Drummond MF, Sculpher MJ, Torance GW et al. Methods for the Economic Evaluation of Health Care Programmes, 3rd edn. Oxford University Press, New York, 2005.
10. Smith RA, Cokkinides V, Eyre HJ. American cancer society guidelines for the early detection of cancer, 2005. CA Cancer J. Clin. 2005 55 : 31 44.